Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8(+) Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
新辅助Durvalumab联合或不联合Tremelimumab治疗对口咽癌患者CD8(+)肿瘤淋巴细胞密度、安全性和疗效的影响:CIAO试验结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-3977
Ferrarotto, Renata; Bell, Diana; Rubin, Maria L; Hutcheson, Katherine A; Johnson, Jason M; Goepfert, Ryan P; Phan, Jack; Elamin, Yasir Y; Torman, Danice K; Warneke, Carla L; Hessel, Amy C; Garden, Adam S; Myers, Jeffrey N; Johnson, Faye M; Lee, J Jack; Sikora, Andrew G; Gillison, Maura L; Glisson, Bonnie S; Gross, Neil D